New Zealand markets close in 1 hour 3 minutes

MRNA Jan 2024 390.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.15000.0000 (0.00%)
As of 11:57AM EDT. Market open.
Full screen
Previous close4.1500
Open4.1000
Bid4.2500
Ask5.8000
Strike390.00
Expiry date2024-01-19
Day's range4.1000 - 4.1500
Contract rangeN/A
Volume7
Open interest131
  • Financial Times

    US FDA panel recommends redesigning Covid vaccine to target Omicron variant

    US government advisers have recommended changing the design of Covid-19 vaccines to target the Omicron variant for a booster campaign aimed at blunting an expected surge of infections in the autumn. Scientists on a Food and Drug Administration advisory committee on Tuesday voted 19 to two in favour of incorporating genetic material from the fast-spreading Omicron variant into a new generation of booster jabs. The recommendation, if approved by US authorities, would pave the way for Moderna and Pfizer to switch manufacturing operations over to making vaccines that experts believe will provide better protection against the most widely circulating Covid variants.

  • Zacks

    Moderna (MRNA) Gains As Market Dips: What You Should Know

    In the latest trading session, Moderna (MRNA) closed at $145.36, marking a +0.76% move from the previous day.

  • Zacks

    Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response

    Pfizer (PFE) and partner BioNTech's (BNTX) Omicron-specific COVID vaccine candidates achieves a higher immune response against the variant in a phase II/III study.